<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the paper the author summarized the results of investigations of vasoactive preparations of various action in patients with ischaemic cerebral circulatory disturbances due to <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>After clinico-rheographie correlations it was concluded that each vasoactive agent should be used taking into account the pathogenetic mechanisms of cerebral circulatory disturbances </plain></SENT>
<SENT sid="2" pm="."><plain>Better results were obtained treating patients with preparations with antihypoxic properties and those influencing cerebral metabolism </plain></SENT>
</text></document>